Evidence map›Paper›PMID 33809358›Full record

ArticlePolymers2021

Flow-Through PolyHIPE Silver-Based Catalytic Reactor.

Rok Mravljak, Ožbej Bizjak, Benjamin Božič, Matejka Podlogar, Aleš Podgornik

Open access · goldAbstract read
In one paragraph

Article in Polymers, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Rok MravljakDepartment of Chemical Engineering and Technical Safety, Faculty for Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Ožbej BizjakDepartment of Chemical Engineering and Technical Safety, Faculty for Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Benjamin BožičDepartment of Chemical Engineering and Technical Safety, Faculty for Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
Matejka PodlogarDepartment of Chemical Engineering and Technical Safety, Faculty for Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia.ORCID 0000-0001-7892-8608
Aleš PodgornikDepartment of Chemical Engineering and Technical Safety, Faculty for Chemistry and Chemical Technology, University of Ljubljana, SI-1000 Ljubljana, Slovenia.
University of Ljubljana · SI

Funding

Javna Agencija za Raziskovalno Dejavnost RS J2-9440Javna Agencija za Raziskovalno Dejavnost RS P1-0153
6 · The paper itself

Abstract

Catalytic reactors performing continuously are an important step towards more efficient and controllable processes compared to the batch operation mode. For this purpose, homogenous high internal phase emulsion polymer materials with an immobilized silver catalyst were prepared and used as a continuous plug flow reactor. Porous material with epoxide groups was functionalized to bear aldehyde groups which were used to reduce silver ions using Tollens reagent. Investigation of various parameters revealed that the mass of deposited silver depends on the aldehyde concentration as well as the composition of Tollens reagent. Nanoparticles formed on the pore surface showed high crystallinity with a cuboctahedra crystal shape and highly uniform surface coverage. The example of the 4-nitrophenol catalytic reduction in a continuous process was studied and demonstrated to be dependent on the mass of deposited silver. Furthermore, productivity increased with the volumetric silver density and flow rate, and it was preserved during prolonged usage and storage.

Indexed as

4-nitrophenol reductionAGET ATRPheterogeneous catalysissilverTollens reagent

Identifiers

PMID33809358
PMCPMC8000888
OpenAlexW3138755609

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.